Could a simple pill combo prevent preterm birth? new trial aims to find out
NCT ID NCT07337655
First seen Jan 19, 2026 · Last updated Jun 19, 2026 · Updated 15 times
Summary
This clinical trial tests whether taking daily low-dose aspirin and lansoprazole can prevent preterm birth in pregnant women at high risk. The study uses a special screening method to identify those most likely to benefit. About 670 women will be enrolled, taking the medication from early pregnancy until delivery, and researchers will compare their outcomes to those receiving standard care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRE-TERM BIRTH are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Stanford University
Palo Alto, California, 94304, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
low-dose aspirin and lansoprazole
What this could lead to
If it works, this could provide a new, safe way to prevent preterm birth in high-risk pregnancies, reducing complications for both mother and baby.
What could go wrong
This is an early-stage trial (Phase II/III) with 670 participants, so results may not apply to all women. The combination may not reduce preterm birth rates or could cause side effects like gastrointestinal issues.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.